Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Prism Medico and Pharmacy Ltd

Your Vote -

Buy

75.00%

Hold

0.00%

Sell

25.00%

75.00%

4 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Prism Medico and Pharmacy Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Prism Medico and Pha - Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirement

    16 Jan 2026, 6:27PM Dear Sir/Madam,\r\n\r\nPursuant to Regulation 13(3) of the SEBI (Listing Obligation and Disclosure Requirements), Regulations, 2015, please find attac
  • Prism Medico and Pha - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    14 Jan 2026, 6:08PM Dear Sir/Madam,\r\n\r\nPursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, pleas
  • Prism Medico and Pha - Compliance-57 (5) : intimation after the end of quarter

    2 Jan 2026, 6:32PM Dear Sir/Madam,\r\n\r\nPursuant to Regulation 57(5) of SEBI(Listing Obligation and Disclosure Requirements) Regulations, 2015, please find attached in
  • Prism Medico and Pha - Intimation Under Regulation 57(4) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations

    31 Dec 2025, 5:35PM Dear Sir/Madam, \r\n\r\nPursuant to Regulation 57(4) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find attached
  • Prism Medico and Pha - Revised Outcome Of The Board Meeting Held On 14Th November, 2025.

    21 Nov 2025, 6:34PM Dear Sir/Madam,\r\n\r\nWith reference to the email dated 21st November, 2025, please find attached revised outcome of the Board meeting held on 14th N
  • Prism Medico and Pha - Board Meeting Intimation for Intimation Of Board Meeting.

    6 Nov 2025, 5:52PM Prism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to con
  • Prism Medico and Pha - Undertaking Of Functional Website.

    27 Oct 2025, 4:51PM Dear Sir/Madam,\r\n\r\nPlease find the attached undertaking of functional website. \r\n\r\nThanking You.

Key fundamentals

Evaluate the intrinsic value of Prism Medico and Pharmacy Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 15.0928 15.1415 15.1614 12.5548 12.9259
Liabilities 15.0928 15.1415 15.1614 12.5548 12.9259
Equity 6.0634 6.0634 6.0634 6.0634 6.0634
Gross Profit -0.0764 -0.1379 -0.097 -0.4899 -0.1625
Net Profit -0.0487 -0.0214 -0.0764 -0.3698 -0.13
Cash From Operating Activities -0.0165 -0.005 2.9542 -2.3789 -0.0514
NPM(%) -7.7 -0.73 -6.01 -4.38 -0.77
Revenue 0.6319 2.9252 1.2705 8.4438 16.7635
Expenses 0.7083 3.0631 1.3676 8.9338 16.9261
ROE(%) -0.31 -0.13 -0.48 -2.36 -0.82

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Prism Medico and Pharmacy Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Sugal and Damani Share Brokers Ltd 68.36 1.12 0.00 11.35 75.99 0.00
360 One Wam Ltd 1196.30 3.85 41.24 713.87 2505.24 0.00
Arman Holdings Ltd 108.80 8.80 680.00 9.46 -0.29 0.00
Asia Capital Ltd 17.37 4.95 26.32 5.62 9.71 0.00

Company Info

Prism Medico And Pharmacy Limited is a Public Company incorporated on 22 March 2002. It is classified as Indian Non-Government Company and is registered at Registrar of Companies, Mumbai. t is inolved in Wholesale on a fee or contract basis. [Includes commission agents, commodity brokers and auctioneers and all other wholesalers who trade on behalf and on the account of others. Activities of self employed auctioneers are included in 74991.] 2010 -Registered Office of the Company has been shifted To E-18, 6th Floor, Everest Bldg, Tardeo, Mumbai - 400 034. 2012 -Company has changed its name from Woolite Mercantile Co.Ltd. to Prism Medico and Pharmacy Ltd. 2014 -Prism Medico and Pharmacy Ltd has informed that the Board of Directors of the Company have appointed Mr. Sachin Sharma as an Executive Director of the Company..

Prism Medico And Pharmacy Limited is a Public Company incorporated on 22 March 2002. It is classified as Indian Non-Government Company and is registered at Registrar of Companies, Mumbai. t is inolved in Wholesale on a fee or contract basis. [Includes commission agents, commodity brokers and auctioneers and all other wholesalers who trade on behalf and on the account of others. Activities of self employed auctioneers are included in 74991.] 2010 -Registered Office of the Company has been shifted To E-18, 6th Floor, Everest Bldg, Tardeo, Mumbai - 400 034. 2012 -Company has changed its name from Woolite Mercantile Co.Ltd. to Prism Medico and Pharmacy Ltd. 2014 -Prism Medico and Pharmacy Ltd has informed that the Board of Directors of the Company have appointed Mr. Sachin Sharma as an Executive Director of the Company..

Read More

Parent Organisation

Prism Medico and Pharmacy Ltd.

Founded

22/03/2002

Managing Director

NSE Symbol

FAQ

The current price of Prism Medico and Pharmacy Ltd is

The 52-week high for Prism Medico and Pharmacy Ltd is

The market capitalization of Prism Medico and Pharmacy Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Prism Medico and Pharmacy Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Prism Medico and Pharmacy Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Prism Medico and Pharmacy Ltd shares.

The CEO of Prism Medico and Pharmacy Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT